Faculty

Brett A. Freedman, M.D.

Clinical Studies

Open

A Phase 1b/2a Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion Rochester, Minn.
The primary purpose of this study is to evaluate the safety and tolerability of ART352-L treated local bone autograft in subjects undergoing a spinal fusion procedure to treat lumbar degenerative spondylolisthesis.

Closed for Enrollment

Prospective, Randomized, Controlled, Blinded Pivotal Study In Subjects Undergoing A Transforaminal Lumbar Interbody Fusion (TLIF) At One Or Two Levels Using Infuse™ Bone Graft with an Intervertebral Body Fusion Device and Posterior Supplemental Fixation For The Treatment Of Symptomatic Degenerative Disease Of The Lumbosacral Spine (TLIF) Rochester, Minn.
The purpose of this study is to evaluate the safety and effectiveness of the investigational treatment compared to the control, and obtain indication expansion for Infuse™ use in one and two level TLIFprocedures.

.

.